BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8218688)

  • 1. An economic evaluation of varicella vaccine for pediatric liver and kidney transplant recipients.
    Kitai IC; King S; Gafni A
    Clin Infect Dis; 1993 Sep; 17(3):441-7. PubMed ID: 8218688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Varicella vaccination in Italy : an economic evaluation of different scenarios.
    Coudeville L; Brunot A; Giaquinto C; Lucioni C; Dervaux B
    Pharmacoeconomics; 2004; 22(13):839-55. PubMed ID: 15329030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of a routine varicella vaccination program for US children.
    Lieu TA; Cochi SL; Black SB; Halloran ME; Shinefield HR; Holmes SJ; Wharton M; Washington AE
    JAMA; 1994 Feb; 271(5):375-81. PubMed ID: 8283587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuated varicella virus vaccine in children with renal transplants.
    Zamora I; Simon JM; Da Silva ME; Piqueras AI
    Pediatr Nephrol; 1994 Apr; 8(2):190-2. PubMed ID: 8018498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varicella vaccine.
    Med Lett Drugs Ther; 1995 Jun; 37(951):55-7. PubMed ID: 7783692
    [No Abstract]   [Full Text] [Related]  

  • 6. Varicella vaccine in children with chronic renal insufficiency.
    Broyer M; Boudailliez B
    Postgrad Med J; 1985; 61 Suppl 4():103-6. PubMed ID: 3014466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live attenuated varicella virus vaccine. Efficacy trial in healthy children.
    Weibel RE; Neff BJ; Kuter BJ; Guess HA; Rothenberger CA; Fitzgerald AJ; Connor KA; McLean AA; Hilleman MR; Buynak EB
    N Engl J Med; 1984 May; 310(22):1409-15. PubMed ID: 6325909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varicella vaccination in pediatric kidney and liver transplantation.
    Prelog M; Zimmerhackl LB
    Pediatr Transplant; 2010 Feb; 14(1):41-7. PubMed ID: 20091941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and safety of immunization with live-attenuated and inactivated vaccines for pediatric liver transplantation recipients.
    Kawano Y; Suzuki M; Kawada J; Kimura H; Kamei H; Ohnishi Y; Ono Y; Uchida H; Ogura Y; Ito Y
    Vaccine; 2015 Mar; 33(12):1440-5. PubMed ID: 25665961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-year follow-up study of recipients of live varicella vaccine using enhanced neutralization and fluorescent antibody membrane antigen assays.
    Asano Y; Albrecht P; Vujcic LK; Quinnan GV; Kawakami K; Takahashi M
    Pediatrics; 1983 Sep; 72(3):291-4. PubMed ID: 6310478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varicella in pediatric patients.
    Drwal-Klein LA; O'Donovan CA
    Ann Pharmacother; 1993; 27(7-8):938-49. PubMed ID: 8395918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of tolerance and effectiveness of a varicella vaccine in leukemic children.
    Bancillon A; Leblanc T; Baruchel A; Schaison G; Leverger G; Mallarmey D; Teuliere L
    Nouv Rev Fr Hematol (1978); 1991; 33(6):555-6. PubMed ID: 1667953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Live attenuated varicella vaccine.
    Gershon AA
    Annu Rev Med; 1987; 38():41-50. PubMed ID: 3034136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
    Kuter B; Matthews H; Shinefield H; Black S; Dennehy P; Watson B; Reisinger K; Kim LL; Lupinacci L; Hartzel J; Chan I;
    Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies.
    Kuter BJ; Weibel RE; Guess HA; Matthews H; Morton DH; Neff BJ; Provost PJ; Watson BA; Starr SE; Plotkin SA
    Vaccine; 1991 Sep; 9(9):643-7. PubMed ID: 1659052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1996 Jul; 45(RR-11):1-36. PubMed ID: 8668119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term protective immunity of recipients of the OKA strain of live varicella vaccine.
    Asano Y; Nagai T; Miyata T; Yazaki T; Ito S; Yamanishi K; Takahashi M
    Pediatrics; 1985 Apr; 75(4):667-71. PubMed ID: 2984636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost containment analysis of childhood vaccination against varicella in Israel.
    Ginsberg GM; Somekh E
    J Infect; 2004 Feb; 48(2):119-33. PubMed ID: 14720487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of Live Attenuated High-Titer Varicella-Zoster Virus Vaccine in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
    Aoki T; Koh K; Kawano Y; Mori M; Arakawa Y; Kato M; Hanada R
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):771-775. PubMed ID: 26748161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varicella vaccine guidelines.
    DiNicola AF
    Pediatrics; 1995 Aug; 96(2 Pt 1):375-6. PubMed ID: 7630706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.